IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, P.
Right arrow Articles by Luscher, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, P.
Right arrow Articles by Luscher, T. F.

Investigative Ophthalmology & Visual Science, Vol 34, 3614-3621, Copyright © 1993 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins

P Meyer, J Flammer and TF Luscher
Department of Research, University Hospital, Basel, Switzerland.

PURPOSE. The endothelium produces nitric oxide and endothelin (ET). This study was designed to investigate the endothelium-dependent regulation of the porcine ophthalmic microcirculation. METHODS. Isolated porcine eyes were perfused with a modified Langendorff setup (Hugo Sachs Elektronik KG, Freiburg, Germany) at a perfusion pressure of 80 cm H2O with Krebs-Ringer bicarbonate solution (37 degrees C; 95% O2, 5% CO2). RESULTS. The inhibitor of nitric oxide formation, L- nitroarginine methylester (L-NAME; 10(-6) to 10(-4) M), evoked decreases in flow (maximal decrease, 39% +/- 6%; P < 0.005 versus control). The endothelium-dependent vasodilator bradykinin evoked increases in ophthalmic flow (maximal increase, 26% +/- 2%; P < 0.05 versus control) prevented by L-NAME. The effect of endothelin-1 (ET-1; 10(-12) to 10(-11) M) on flow was biphasic, with early vasodilation (1 to 2 minutes) and late vasoconstriction. At 10(-12) M, the increase in flow was most pronounced (24% +/- 5%; P < 0.05 versus control), whereas 10(-10) M caused only significant decreases in flow (59% +/- 5%; P < 0.001 versus control). Endothelin-3 (ET-3) evoked similar vasodilator effects as ET-1 but less vasoconstriction. The vasodilator effects of ET-3 were prevented by pretreatment of the eye with indomethacin (10(- 5) M, to block the production of prostaglandins; P < 0.05 versus control). The endothelinA receptor antagonist FR-139317 significantly reduced vasoconstriction to ET-1 (10(-10) M; P < 0.001 versus control). The thromboxane analogue (U-46619) reduced flow in a concentration- dependent manner (P < 0.001 versus control). CONCLUSIONS. Endothelium- derived nitric oxide released under basal conditions or stimulated by bradykinin significantly regulated flow to the porcine ophthalmic microcirculation. This vasodilator system may play an important protective role against vasospasm. In contrast, ET-1 has vasodilator effects through the release of prostaglandins and potent vasoconstrictor properties mediated through ETA receptors.


This article has been cited by other articles:


Home page
IOVSHome page
N. Izumi, T. Nagaoka, E. Sato, K. Sogawa, H. Kagokawa, A. Takahashi, A. Kawahara, and A. Yoshida
Role of Nitric Oxide in Regulation of Retinal Blood Flow in Response to Hyperoxia in Cats
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4595 - 4603.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Henry, D. E. Newby, D. J. Webb, P. W. F. Hadoke, and C. J. O'Brien
Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2528 - 2532.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. D. Gilmore, C. Hudson, S. T. Venkataraman, D. Preiss, and J. Fisher
Comparison of Different Hyperoxic Paradigms to Induce Vasoconstriction: Implications for the Investigation of Retinal Vascular Reactivity
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3207 - 3212.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
F Galassi, G Renieri, A Sodi, F Ucci, L Vannozzi, and E Masini
Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma
Br. J. Ophthalmol., June 1, 2004; 88(6): 757 - 760.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
G. Fuchsjager-Mayrl, A. Luksch, M. Malec, E. Polska, M. Wolzt, and L. Schmetterer
Role of Endothelin-1 in Choroidal Blood Flow Regulation during Isometric Exercise in Healthy Humans
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 728 - 733.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Polak, V. Petternel, A. Luksch, J. Krohn, O. Findl, E. Polska, and L. Schmetterer
Effect of Endothelin and BQ123 on Ocular Blood Flow Parameters in Healthy Subjects
Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2949 - 2956.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. F. E. Nilsson, O. Mäepea, A. Alm, and K. Narfström
Ocular Blood Flow and Retinal Metabolism in Abyssinian Cats with Hereditary Retinal Degeneration
Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1038 - 1044.
[Abstract] [Full Text]


Home page
IOVSHome page
F. Mori, G. L. King, A. C. Clermont, D. K. Bursell, and S.-E. Bursell
Endothelin-3 Regulation of Retinal Hemodynamics in Nondiabetic and Diabetic Rats
Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3955 - 3962.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
T. W. Kim, K. B. Kang, H.-K. Choung, K. H. Park, and D. M. Kim
Elevated Glutamate Levels in the Vitreous Body of an In Vivo Model of Optic Nerve Ischemia
Arch Ophthalmol, April 1, 2000; 118(4): 533 - 536.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Henry, D. E. Newby, D. J. Webb, and C. O’Brien
Peripheral Endothelial Dysfunction in Normal Pressure Glaucoma
Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1710 - 1714.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J. E Grunwald, A. Iannaccone, and J. DuPont
Effect of isosorbide mononitrate on the human optic nerve and choroidal circulations
Br. J. Ophthalmol., February 1, 1999; 83(2): 162 - 167.
[Abstract] [Full Text]


Home page
Br. J. Ophthalmol.Home page
C. H Buckley, P. W F Hadoke, and C. J O'Brien
Role of the endothelium in modulating functional responses of isolated bovine anterior ciliary arteries to vasoconstrictor agonists
Br. J. Ophthalmol., July 1, 1998; 82(7): 826 - 829.
[Abstract] [Full Text]


Home page
Br. J. Ophthalmol.Home page
A. Iannaccone, C. Letizia, S. Pazzaglia, E. M Vingolo, G. Clemente, and M. R Pannarale
Plasma endothelin-1 concentrations in patients with retinal vein occlusions
Br. J. Ophthalmol., May 1, 1998; 82(5): 498 - 503.
[Abstract] [Full Text]


Home page
Br. J. Ophthalmol.Home page
C. H BUCKLEY, P. W F HADOKE, and C. J O'BRIEN
Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma
Br. J. Ophthalmol., July 1, 1997; 81(7): 599 - 607.
[Full Text] [PDF]


Home page
CirculationHome page
R. R. Wenzel, N. Duthiers, G. Noll, J. Bucher, U. Kaufmann, and T. F. Luscher
Endothelin and Calcium Antagonists in the Skin Microcirculation of Patients With Coronary Artery Disease
Circulation, August 1, 1996; 94(3): 316 - 322.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. Takase, P. Moreau, and T. F. Luscher
Endothelin Receptor Subtypes in Small Arteries : Studies With FR139317 and Bosentan
Hypertension, April 1, 1995; 25(4): 739 - 743.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association for Research in Vision and Ophthalmology